Long noncoding RNA in prostate, bladder, and kidney cancer

Elena S Martens-Uzunova1, René Böttcher2, Carlo M Croce3

  • 1Department of Urology, Erasmus Medical Centre, Rotterdam, The Netherlands.

European Urology
|December 31, 2013
PubMed
Abstract

Insights

Long noncoding RNAs (lncRNAs) are crucial in urologic cancers like prostate, bladder, and kidney. These molecules show promise as noninvasive biomarkers and potential therapeutic targets for cancer detection and treatment.

Area of Science:

  • Molecular Biology
  • Genomics
  • Oncology

Background:

  • Genomic regions lacking protein-coding potential produce numerous noncoding RNAs (ncRNAs).
  • Long noncoding RNAs (lncRNAs) are increasingly recognized for their roles in cellular processes.
  • Evidence suggests lncRNAs are frequently altered in human urologic cancers.

Purpose of the Study:

  • To review the biology and implications of lncRNAs in prostate, bladder, and kidney cancer.
  • To explore the potential of lncRNAs as biomarkers and therapeutic targets in urologic malignancies.

Main Methods:

  • Systematic literature search of the PubMed database.
  • Inclusion of English-language articles using specific MeSH terms related to lncRNAs and urologic cancers.

Main Results:

  • Summarized current knowledge on lncRNA systematics, biology, and function in prostate, kidney, and bladder cancers.
  • Discussed the utility of lncRNAs as novel biomarkers and therapeutic targets.
  • Highlighted challenges and future perspectives in lncRNA research.

Conclusions:

  • lncRNAs regulate gene expression critical for cell growth, proliferation, differentiation, and survival.
  • Dysfunctional lncRNAs contribute to tumor formation, progression, and metastasis in urologic cancers.
  • lncRNAs offer potential as noninvasive tumor markers and future therapeutic targets, warranting further research into their biologic functions.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
7.5K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

2.6K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
12.4K
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
53.3K